-
1
-
-
0036822175
-
Verteporfin therapy for subfoveal choroidal neovascularization in age related macular degeneration: Three-year results of an open-label extension of 2 randomized clinical trials - TAP report 5
-
Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy for subfoveal choroidal neovascularization in age related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials - TAP report 5. Arch Ophthalmol 2002;120:1307-1314.
-
(2002)
Arch Ophthalmol
, vol.120
, pp. 1307-1314
-
-
-
2
-
-
0036293893
-
Benefits and complications of photodynamic therapy of papillary capillary hemangiomas
-
Schmidt-Erfurth U, Kusserow C, Barbazetto I, et al. Benefits and complications of photodynamic therapy of papillary capillary hemangiomas. Ophthalmology 2002;109:1256-1266.
-
(2002)
Ophthalmology
, vol.109
, pp. 1256-1266
-
-
Schmidt-Erfurth, U.1
Kusserow, C.2
Barbazetto, I.3
-
3
-
-
0028852924
-
Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes
-
Macular Photocoagulation Study Group
-
The Macular Photocoagulation Study Group. Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Macular Photocoagulation Study Group. Arch Ophthalmol 1995;113:56-61.
-
(1995)
Arch Ophthalmol
, vol.113
, pp. 56-61
-
-
-
4
-
-
0025613305
-
Thermal papillitis after dye red photocoagulation of a peripapillary choroidal neovascular membrane
-
Bloom S. Thermal papillitis after dye red photocoagulation of a peripapillary choroidal neovascular membrane. Retina 1990;10:261-264.
-
(1990)
Retina
, vol.10
, pp. 261-264
-
-
Bloom, S.1
-
5
-
-
0020610889
-
Sudden severe visual loss associated with peripapillary burns during panretinal argon photocoagulation
-
Swartz M, Apple D, Creel D. Sudden severe visual loss associated with peripapillary burns during panretinal argon photocoagulation. Br J Ophthalmol 1983;67:517-519.
-
(1983)
Br J Ophthalmol
, vol.67
, pp. 517-519
-
-
Swartz, M.1
Apple, D.2
Creel, D.3
-
6
-
-
0342632445
-
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with Verteporfin: One-year results of 2 randomized clinical trials - TAP Report 1
-
Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with Verteporfin: one-year results of 2 randomized clinical trials - TAP Report 1. Arch Ophthalmol 1999;117:1329-1345.
-
(1999)
Arch Ophthalmol
, vol.117
, pp. 1329-1345
-
-
-
7
-
-
0009606162
-
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-Year results of a randomized clinical trial - VIP report no. 1
-
Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial - VIP report no. 1. Am J Ophthalmol 2001;131:541-560.
-
(2001)
Am J Ophthalmol
, vol.131
, pp. 541-560
-
-
-
8
-
-
0036343021
-
Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: One-year results of an uncontrolled, prospective case series
-
Saperstein D, Rosenfeld P, Bressler N, et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series. Ophthalmology 2002;109:1499-1505.
-
(2002)
Ophthalmology
, vol.109
, pp. 1499-1505
-
-
Saperstein, D.1
Rosenfeld, P.2
Bressler, N.3
-
9
-
-
0036294195
-
Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin
-
Spaide RF, Martin ML, Slakter J, et al. Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin. Am J Ophthalmol 2002;134:62-68.
-
(2002)
Am J Ophthalmol
, vol.134
, pp. 62-68
-
-
Spaide, R.F.1
Martin, M.L.2
Slakter, J.3
-
10
-
-
0036741945
-
Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks
-
Karacorlu M, Karacorlu S, Ozdemir H, et al. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol 2002;134:360-366.
-
(2002)
Am J Ophthalmol
, vol.134
, pp. 360-366
-
-
Karacorlu, M.1
Karacorlu, S.2
Ozdemir, H.3
-
11
-
-
85031454141
-
-
Verteporfin in Photodynamic Therapy (VIP) Study Group
-
Ruiz-Oliva F, Cortes J. Verteporfin in Photodynamic Therapy (VIP) Study Group. Ophthalmology 2002;109:1043.
-
(2002)
Ophthalmology
, vol.109
, pp. 1043
-
-
Ruiz-Oliva, F.1
Cortes, J.2
-
12
-
-
0035124965
-
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: Two-year results of 2 randomized clinical trials - TAP report 2
-
Bressler NM, The Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group (TAP). Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials - TAP report 2. Arch Ophthalmol 2001;119:198-207.
-
(2001)
Arch Ophthalmol
, vol.119
, pp. 198-207
-
-
Bressler, N.M.1
-
13
-
-
0037742639
-
Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome
-
Busquets M, Shah G, Wickens J, et al. Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome. Retina 2003;23:299-306.
-
(2003)
Retina
, vol.23
, pp. 299-306
-
-
Busquets, M.1
Shah, G.2
Wickens, J.3
-
14
-
-
0036732979
-
Photodynamic therapy for choroidal hemangioma associated with serous retinal detachment
-
Robertson DM. Photodynamic therapy for choroidal hemangioma associated with serous retinal detachment. Arch Ophthalmol 2002;120:1155-1161.
-
(2002)
Arch Ophthalmol
, vol.120
, pp. 1155-1161
-
-
Robertson, D.M.1
|